US Navy cancels MASC programme, launches $2.1bn MUSV marketplace as the Golden Fleet strategy moves from concept to procurement
No Kings protests return to New York City for third time as nationwide mobilisation targets Trump administration policies
Read More 5 minute read Pharma Industry News Abbisko Therapeutics’ pimicotinib clears FDA filing hurdle: Why this matters for rare tumor strategy and global biotech credibility Abbisko Therapeutics clears a key FDA hurdle for pimicotinib. Find out why this TGCT filing could reshape rare tumor strategy and global biotech credibility. byPallavi MadhirajuJanuary 14, 2026